Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 105
12
Diseases
24
Unique genes
0.196
Avg. similarity score
Malt lymphoma
Most-connected disease (7 links)
Disease
Searched: Abnormality of brain morphology
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Abnormality of brain morphology
Malt lymphoma
Mucosa-associated lymphoma
Splenic diffuse red pulp small b-cell lymphoma
Pyogenic bacterial infections, recurrent
Hajdu-cheney syndrome
Radiologic finding
Waldenstrom macroglobulinemia
Alagille syndrome
Autoinflammatory syndrome, familial, behcet-like
Follicular cyst
Immunodeficiency 37
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Malt lymphoma | 7 | 7 | 9 |
| Mucosa-associated lymphoma | 6 | 6 | 4 |
| Splenic diffuse red pulp small b-cell lymphoma | 6 | 6 | 2 |
| Pyogenic bacterial infections, recurrent | 5 | 5 | 1 |
| Hajdu-cheney syndrome | 4 | 4 | 1 |
| Radiologic finding | 4 | 4 | 10 |
| Waldenstrom macroglobulinemia | 4 | 4 | 4 |
| Alagille syndrome | 3 | 3 | 2 |
| Autoinflammatory syndrome, familial, behcet-like | 3 | 3 | 1 |
| Follicular cyst | 3 | 3 | 2 |
| Immunodeficiency 37 | 2 | 2 | 1 |
| Abnormality of brain morphology | 1 | 1 | 2 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| MYD88 | 6 / 12 | Malt lymphoma, Mucosa-associated lymphoma, Pyogenic bacterial infections, recurrent, Radiologic finding and 2 more |
| NOTCH2 | 5 / 12 | Alagille syndrome, Follicular cyst, Hajdu-cheney syndrome, Malt lymphoma and 1 more |
| TNFAIP3 | 4 / 12 | Autoinflammatory syndrome, familial, behcet-like, Malt lymphoma, Mucosa-associated lymphoma, Radiologic finding |
| BCL10 | 3 / 12 | Immunodeficiency 37, Malt lymphoma, Mucosa-associated lymphoma |
| EXOC2 | 2 / 12 | Abnormality of brain morphology, Waldenstrom macroglobulinemia |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| NF-kappa B signaling pathway | KEGG | 6 / 105 | 28.6× | 4.58e-8 | 2.82e-6 ✓ sig. |
| Regulation of TP53 Expression | Reactome | 2 / 2 | 500× | 3.83e-6 | 1.31e-4 ✓ sig. |
| Regulation of TP53 Activity through Methylation | Reactome | 3 / 19 | 79.0× | 6.65e-6 | 2.08e-4 ✓ sig. |
| Pre-NOTCH Transcription and Translation | Reactome | 3 / 31 | 48.4× | 3.04e-5 | 7.32e-4 ✓ sig. |
| Human papillomavirus infection | KEGG | 6 / 333 | 9.0× | 3.83e-5 | 8.84e-4 ✓ sig. |
| Pathways in cancer | KEGG | 7 / 533 | 6.6× | 5.83e-5 | 1.23e-3 ✓ sig. |
| Regulation of FOXO transcriptional activity by acetylation | Reactome | 2 / 7 | 143× | 7.99e-5 | 1.58e-3 ✓ sig. |
| TNF signaling pathway | KEGG | 4 / 119 | 16.8× | 8.35e-5 | 1.65e-3 ✓ sig. |
| Thyroid hormone signaling pathway | KEGG | 4 / 122 | 16.4× | 9.20e-5 | 1.78e-3 ✓ sig. |
| Shigellosis | KEGG | 5 / 250 | 10.0× | 1.15e-4 | 2.12e-3 ✓ sig. |
| PI5P Regulates TP53 Acetylation | Reactome | 2 / 9 | 111× | 1.37e-4 | 2.43e-3 ✓ sig. |
| Measles | KEGG | 4 / 139 | 14.4× | 1.53e-4 | 2.65e-3 ✓ sig. |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | Reactome | 3 / 58 | 25.9× | 2.01e-4 | 3.30e-3 ✓ sig. |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | Reactome | 3 / 58 | 25.9× | 2.01e-4 | 3.30e-3 ✓ sig. |
| Stabilization of p53 | Reactome | 2 / 11 | 91.0× | 2.08e-4 | 3.39e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| apoptotic process | GO:0006915 | 10 / 747 | 10.4× | 1.16e-8 | 2.00e-6 ✓ sig. |
| regulation of apoptotic process | GO:0042981 | 7 / 254 | 21.5× | 2.24e-8 | 3.56e-6 ✓ sig. |
| lipopolysaccharide-mediated signaling pathway | GO:0031663 | 4 / 38 | 82.0× | 1.50e-7 | 1.79e-5 ✓ sig. |
| regulation of cell population proliferation | GO:0042127 | 6 / 201 | 23.2× | 1.65e-7 | 1.93e-5 ✓ sig. |
| cardiac septum morphogenesis | GO:0060411 | 3 / 16 | 146× | 1.03e-6 | 8.79e-5 ✓ sig. |
| regulation of chemokine (C-X-C motif) ligand 2 production | GO:2000341 | 2 / 4 | 389× | 9.47e-6 | 5.21e-4 ✓ sig. |
| ciliary body morphogenesis | GO:0061073 | 2 / 4 | 389× | 9.47e-6 | 5.21e-4 ✓ sig. |
| positive regulation of canonical NF-kappaB signal transduction | GO:0043123 | 5 / 232 | 16.8× | 9.90e-6 | 5.40e-4 ✓ sig. |
| intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | GO:0042771 | 3 / 33 | 70.8× | 9.90e-6 | 5.40e-4 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 9 / 1,208 | 5.8× | 1.03e-5 | 5.56e-4 ✓ sig. |
| non-canonical NF-kappaB signal transduction | GO:0038061 | 3 / 34 | 68.7× | 1.09e-5 | 5.79e-4 ✓ sig. |
| multicellular organism growth | GO:0035264 | 4 / 115 | 27.1× | 1.32e-5 | 6.72e-4 ✓ sig. |
| positive regulation of interleukin-2 production | GO:0032743 | 3 / 37 | 63.1× | 1.41e-5 | 7.09e-4 ✓ sig. |
| cellular response to hyperoxia | GO:0071455 | 2 / 5 | 311× | 1.58e-5 | 7.74e-4 ✓ sig. |
| response to fungus | GO:0009620 | 2 / 6 | 260× | 2.36e-5 | 1.05e-3 ✓ sig. |